FDA Adverse Event Other Summary report: N

GELSOFT PLUS - BIFURCATE

MDR report key: 2887639 · Received November 30, 2012

Report

Report Number
9612515-2012-00020
Event Type
Other
Date Received
November 30, 2012
Date of Event
May 24, 2012
Report Date
November 26, 2012
Manufacturer
VASCUTEK LTD.
Product Code
DSY
PMA / PMN Number
K955230
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

METHOD - NO INSPECTION AND EVAL OF THE DEVICE HAS BEEN POSSIBLE AS THE EXPLANTED SECTION OF GRAFT IS CURRENTLY EN-ROUTE TO VASCUTEK. RESULTS - AS NO PRODUCT IS CURRENTLY AVAILABLE FOR INSPECTION AND EVAL A REVIEW OF THE MFG RECORDS ASSOCIATED WITH THE AFFECTED PRODUCT (GELSOFT PLUS VASCULAR PROSTHESIS, LOT NO 1117411 3020, S/N (B)(4)) WAS UNDERTAKEN; THIS CONFIRMED THAT THE PRODUCT WAS MANUFACTURED WITHIN SPECS. CONCLUSION CODE - NO CONCLUSION CAN BE DRAWN. AS NO PRODUCT HAS BEEN RETURNED FOR INSPECTION AND EVAL TO DATE, THE ROOT CAUSE OF THE REPORTED DEFECT COULD NOT BE ESTABLISHED AT THIS TIME. ONCE THE SECTION OF GRAFT HAS BEEN RETURNED TO VASCUTEK; AND OUR INSPECTION AND EVAL PROCESS IS COMPLETE, A F/U INCIDENT REPORT WILL BE ISSUED.

Description of Event or Problem · 1

VASCUTEK HAS BEEN NOTIFIED OF AN INCIDENT VIA OUR (B)(4) DISTRIBUTOR (VASCUTEK (B)(4)); THAT OCCURRED IN THE (B)(6) ON (B)(6) 2012. OF NOTE VASCUTEK WAS NOT INFORMED OF THE INCIDENT UNTIL (B)(6) 2012. THE INCIDENT WAS DESCRIBED AS FOLLOWS: DR. (B)(6) PERFORMED AN ELECTIVE SURGICAL PROCEDURE TO IMPLANT A GELSOFT PLUS BIFURCATE GRAFT TO A PT. DURING THE PROCEDURE, THE SURGEON ENCOUNTERED POROSITY ISSUES (LEAKAGE) IN THE MAIN BODY AND THE LEFT LEG OF THE GRAFT. THE SURGEON ATTEMPTED TO STOP THE LEAKAGE BY USING ADD'L GAUZE AND BY USING SURGICAL (BIO-GLUE). A SECTION OF THE GRAFT WAS REMOVED AND WILL BE SENT BACK TO VASCUTEK FOR INSPECTION AND EVAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GELSOFT PLUS - BIFURCATE VASCULAR PROSTHESIS DSY VASCUTEK LTD. NA 117411 3020

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention